Nantahala Capital Management, LLC
Reported holdings as of Q2 2026, from 31 quarterly filings.
Holdings
| Security | Ticker | Value | Shares | Weight | Weight change | Held | Change |
|---|---|---|---|---|---|---|---|
| ISHARES TR OPT | IWM | $1.2B | options only | +1.25pp | 31q | OPTIONS | |
| PELOTON INTERACTIVE INC OPT | PTON | $254.7M | 10,217,990 | -0.50pp | 21q | -14.9%-$44.4M | |
| HILTON GRAND VACATIONS INC OPT | HGV | $220.8M | 2,066,340 | -0.06pp | 15q | +36.5%+$59.1M | |
| HERBALIFE LTD OPT | HLF | $202.8M | 2,218,308 | -0.40pp | 21q | +63.9%+$79.0M | |
| BANCORP INC DEL OPT | TBBK | $171.1M | 2,479,774 | -0.14pp | 9q | +79.6%+$75.8M | |
| VIATRIS INC OPT | VTRS | $158.8M | options only | +0.15pp | 5q | OPTIONS | |
| EDWARDS LIFESCIENCES CORP OPT | EW | $144.7M | options only | +0.05pp | 4q | OPTIONS | |
| UNIQURE NV OPT | QURE | $130.5M | 911,320 | +0.46pp | 31q | +284.4%+$96.6M | |
| SPDR SERIES TRUST OPT | XBI | $126.6M | options only | +0.69pp | 12q | OPTIONS | |
| BIOVENTUS INC | BVS | $113.3M | 12,000,558 | -0.18pp | 16q | +96.0%+$55.5M | |
| SAVARA INC | SVRA | $86.0M | 13,953,620 | -0.05pp | 12q | +90.0%+$40.7M | |
| ETON PHARMACEUTICALS INC | ETON | $85.1M | 2,351,902 | +0.35pp | 9q | +100.0%+$42.6M | |
| AMNEAL PHARMACEUTICALS INC | AMRX | $78.5M | 4,537,502 | flat | 14q | +59.5%+$29.3M | |
| EVOLUS INC | EOLS | $77.8M | 11,204,042 | +0.33pp | 12q | +75.7%+$33.5M | |
| ABEONA THERAPEUTICS INC OPT | ABEO | $76.1M | 10,272,980 | +0.27pp | 15q | +104.9%+$39.0M | |
| ETF SER SOLUTIONS OPT | QTUM | $73.8M | options only | - | new | OPTIONS | |
| FOX FACTORY HLDG CORP OPT | FOXF | $71.5M | 2,621,390 | -0.20pp | 7q | +76.1%+$30.9M | |
| CAMPING WORLD HLDGS INC OPT | CWH | $69.4M | 5,102,110 | -0.17pp | 5q | +56.5%+$25.1M | |
| AVALO THERAPEUTICS INC | AVTX | $68.8M | 3,724,500 | +0.46pp | 6q | +201.6%+$46.0M | |
| LB PHARMACEUTICALS INC | LBRX | $68.3M | 2,105,788 | +0.18pp | 4q | +100.0%+$34.2M | |
| NEUROCRINE BIOSCIENCES INC OPT | NBIX | $67.4M | options only | - | new | OPTIONS | |
| PRAXIS PRECISION MEDICINES I OPT | PRAX | $67.0M | options only | - | new | OPTIONS | |
| ANTERIS TECHNOLOGIES GLOBAL | AVR | $66.7M | 6,766,670 | -0.02pp | 7q | +22.3%+$12.2M | |
| RIDENOW GROUP INC OPT | RDNW | $66.2M | 6,545,690 | -0.19pp | 17q | +100.0%+$33.1M | |
| KRYSTAL BIOTECH INC OPT | KRYS | $63.2M | options only | - | new | OPTIONS | |
| ESTABLISHMENT LABS HLDGS INC | ESTA | $57.6M | 671,660 | -0.78pp | 31q | -19.4%-$13.8M | |
| XTANT MED HLDGS INC | XTNT | $57.6M | 136,788,000 | -0.45pp | 12q | +100.0%+$28.8M | |
| JACK IN THE BOX INC | JACK | $54.7M | 3,457,318 | +0.36pp | 5q | +124.1%+$30.3M | |
| GOGO INC | GOGO | $53.9M | 17,395,462 | -0.42pp | 3q | +95.8%+$26.4M | |
| IMAX CORP | IMAX | $52.5M | 1,316,018 | +0.15pp | 23q | +155.3%+$31.9M | |
| ZEVRA THERAPEUTICS INC | ZVRA | $51.6M | 3,594,952 | -0.01pp | 12q | +42.5%+$15.4M | |
| REGENERON PHARMACEUTICALS OPT | REGN | $49.9M | options only | -0.31pp | 4q | OPTIONS | |
| TITAN MACHY INC | TITN | $47.9M | 2,266,176 | +0.02pp | 8q | +80.6%+$21.4M | |
| RMR GROUP INC | RMR | $47.1M | 2,295,804 | +0.13pp | 23q | +100.0%+$23.6M | |
| FOSSIL GROUP INC | FOSL | $45.6M | 11,010,256 | -0.10pp | 13q | +103.7%+$23.2M | |
| SNAP INC OPT | SNAP | $44.4M | 400,000 | - | new | NEW | |
| MINERALYS THERAPEUTICS INC | MLYS | $44.3M | 1,640,962 | -0.16pp | 10q | +83.2%+$20.1M | |
| AURA BIOSCIENCES INC | AURA | $41.9M | 5,902,060 | +0.17pp | 19q | +178.7%+$26.9M | |
| AGOMAB THERAPEUTICS NV | AGMB | $40.7M | 3,136,376 | +0.20pp | 2q | +161.4%+$25.1M | |
| FULCRUM THERAPEUTICS INC | FULC | $40.1M | 10,950,080 | -0.20pp | 8q | +259.0%+$28.9M | |
| BENITEC BIOPHARMA INC | BNTC | $39.8M | 2,976,742 | +0.10pp | 9q | +107.0%+$20.6M | |
| ADMA BIOLOGICS INC | ADMA | $39.5M | 4,719,986 | - | new | NEW | |
| BIOCRYST PHARMACEUTICALS INC | BCRX | $38.0M | 3,802,320 | -0.06pp | 3q | +91.3%+$18.1M | |
| MIMEDX GROUP INC | MDXG | $36.7M | 9,535,104 | +0.12pp | 4q | +180.7%+$23.6M | |
| ABIVAX SA | ABVX | $35.6M | 267,518 | +0.03pp | 11q | +94.9%+$17.4M | |
| USANA HEALTH SCIENCES INC | USNA | $34.6M | 1,620,148 | +0.05pp | 3q | +100.0%+$17.3M | |
| CHIME FINL INC OPT | CHYM | $31.6M | 344,238 | -0.03pp | 3q | +72.1%+$13.3M | |
| MONTE ROSA THERAPEUTICS INC | GLUE | $31.6M | 1,303,986 | +0.13pp | 3q | +100.0%+$15.8M | |
| TANGO THERAPEUTICS INC | TNGX | $31.3M | 1,001,318 | -0.44pp | 7q | -19.9%-$7.8M | |
| GERON CORP | GERN | $31.3M | 24,450,000 | -0.10pp | 4q | +117.8%+$16.9M | |
| VOR BIOPHARMA INC | VOR | $31.1M | 1,690,000 | - | new | NEW | |
| KEROS THERAPEUTICS INC | KROS | $30.2M | 2,820,838 | -0.05pp | 25q | +107.4%+$15.6M | |
| VAXCYTE INC OPT | PCVX | $29.9M | 444,292 | -0.09pp | 3q | +86.1%+$13.8M | |
| SILENCE THERAPEUTICS PLC | SLN | $29.6M | 2,693,462 | +0.07pp | 10q | +25.5%+$6.0M | |
| APYX MEDICAL CORPORATION | APYX | $29.4M | 6,540,496 | +0.02pp | 7q | +90.1%+$13.9M | |
| JEFFERSON CAPITAL INC | JCAP | $29.2M | 1,500,000 | -0.05pp | 5q | +100.0%+$14.6M | |
| PLANET FITNESS MASTER ISSUER | PLNT | $29.1M | 558,000 | - | new | NEW | |
| RH OPT | RH | $28.6M | 73,372 | -0.08pp | 6q | +27.0%+$6.1M | |
| VERASTEM INC | VSTM | $27.4M | 7,169,640 | -0.24pp | 9q | +100.0%+$13.7M | |
| DISTRIBUTION SOLUTIONS GRP I | DSGR | $27.1M | 989,162 | -0.03pp | 5q | +100.0%+$13.5M | |
| RAYONIER ADVANCED MATLS INC | RYAM | $26.7M | 3,395,452 | -0.21pp | 4q | +112.2%+$14.1M | |
| HELIX ACQUISITION CORP III | HLXC | $26.6M | 2,500,000 | -0.03pp | 2q | +100.0%+$13.3M | |
| ADC THERAPEUTICS SA | ADCT | $26.4M | 24,652,368 | -0.33pp | 5q | +340.4%+$20.4M | |
| OPUS GENETICS INC | IRD | $25.2M | 6,122,718 | +0.14pp | 6q | +264.2%+$18.3M | |
| JANUX THERAPEUTICS INC | JANX | $24.9M | 1,619,828 | flat | 2q | +100.0%+$12.4M | |
| AMANAT ACQUISITION CORP | AMAN | $24.4M | 2,400,000 | - | new | NEW | |
| INSPIRE MED SYS INC | INSP | $24.0M | 538,948 | - | new | NEW | |
| 1 800 FLOWERS COM INC | FLWS | $23.5M | 6,750,130 | +0.01pp | 5q | +100.0%+$11.7M | |
| X4 PHARMACEUTICALS INC | XFOR | $22.9M | 4,898,936 | +0.01pp | 4q | +100.0%+$11.4M | |
| INTEGER HLDGS CORP | ITGR | $20.8M | 222,604 | -0.21pp | 3q | +29.4%+$4.7M | |
| INVENTIVA SA | IVA | $20.3M | 5,372,786 | - | new | NEW | |
| INDUSTRIAL LOGISTICS PPTYS T | ILPT | $19.7M | 2,222,306 | -0.02pp | 14q | +32.4%+$4.8M | |
| DUOLINGO INC | DUOL | $19.3M | 167,754 | -0.04pp | 2q | +67.8%+$7.8M | |
| RESERVOIR MEDIA INC | RSVR | $18.6M | 1,881,920 | -0.03pp | 12q | +100.0%+$9.3M | |
| FRACTYL HEALTH INC | GUTS | $17.9M | 22,578,192 | +0.07pp | 4q | +68.9%+$7.3M | |
| DHI GROUP INC | DHX | $17.6M | 4,748,054 | +0.05pp | 31q | +100.0%+$8.8M | |
| AMYLYX PHARMACEUTICALS INC | AMLX | $17.5M | 973,368 | +0.02pp | 8q | +81.7%+$7.9M | |
| KORRO BIO INC | KRRO | $17.4M | 1,320,072 | +0.01pp | 3q | +100.0%+$8.7M | |
| ALECTOR INC | ALEC | $17.4M | 8,636,218 | +0.07pp | 2q | +206.7%+$11.7M | |
| NOODLES & CO | NDLS | $16.6M | 1,107,492 | +0.10pp | 2q | +100.0%+$8.3M | |
| CODEXIS INC | CDXS | $16.4M | 7,247,226 | +0.02pp | 31q | +75.7%+$7.1M | |
| PERSPECTIVE THERAPEUTICS INC | CATX | $15.9M | 4,650,900 | - | new | NEW | |
| IRENIC ACQUISITION CORP | $15.2M | 1,500,000 | - | new | NEW | ||
| DAMORA THERAPEUTICS INC | DMRA | $14.5M | 556,000 | -0.02pp | 2q | +100.0%+$7.2M | |
| VIEMED HEALTHCARE INC | VMD | $14.4M | 1,264,890 | -0.06pp | 28q | +43.1%+$4.3M | |
| UNICYCIVE THERAPEUTICS INC | UNCY | $13.1M | 2,802,894 | -0.01pp | 5q | +198.4%+$8.7M | |
| TRAEGER INC | COOK | $13.1M | 165,662 | +0.11pp | 2q | +61.8%+$5.0M | |
| FORRESTER RESH INC | FORR | $12.8M | 1,526,892 | +0.07pp | 2q | +119.9%+$7.0M | |
| LEXEO THERAPEUTICS INC | LXEO | $12.1M | 2,600,000 | -0.05pp | 3q | +116.7%+$6.5M | |
| ENVOY MEDICAL INC | COCH | $11.9M | 15,300,000 | +0.01pp | 2q | +100.0%+$6.0M | |
| ELOXX PHARMACEUTICALS INC | $11.1M | 800,000 | - | new | NEW | ||
| INHIBIKASE THERAPEUTICS INC | IKT | $11.0M | 5,403,726 | +0.02pp | 7q | +100.0%+$5.5M | |
| FIRST TRACKS BIOTHERAPEUTICS | TRAX | $10.1M | 500,000 | - | new | NEW | |
| MARA HOLDINGS INC | $10.0M | 10,000,000 | flat | 3q | DEBT | ||
| HAIN CELESTIAL GROUP INC | HAIN | $9.6M | 17,057,578 | -0.06pp | 5q | +100.0%+$4.8M | |
| ALTA EQUIPMENT GROUP INC | ALTG | $9.4M | 1,449,548 | -0.03pp | 26q | +55.1%+$3.3M | |
| ORTHOPEDIATRICS CORP | KIDS | $9.3M | 484,684 | +0.04pp | 4q | +143.0%+$5.5M | |
| ALTIMMUNE INC | ALT | $9.1M | 3,000,000 | - | new | NEW | |
| TRISALUS LIFE SCIENCES INC | TLSI | $9.1M | 2,000,000 | -0.15pp | 5q | -3.4%-$322.3K | |
| SERVICE PPTYS TR | SVC | $9.0M | 5,322,641 | -0.20pp | 7q | -24.6%-$2.9M | |
| TELA BIO INC | TELA | $8.8M | 11,788,228 | +0.01pp | 16q | +129.2%+$5.0M | |
| THE ONE GROUP HOSPITALITY IN | STKS | $8.5M | 4,242,168 | flat | 10q | +100.0%+$4.3M | |
| DARIOHEALTH CORP | DRIO | $8.1M | 1,221,382 | -0.05pp | 4q | +100.0%+$4.0M | |
| IMMUNIC INC | IMUX | $7.7M | 501,292 | - | new | NEW | |
| ZAI LAB LTD | ZLAB | $7.6M | 400,000 | - | new | NEW | |
| TALPHERA INC | TLPH | $7.2M | 6,985,038 | +0.02pp | 12q | +100.0%+$3.6M | |
| VENU HLDG CORP | VENU | $6.9M | 3,093,410 | -0.13pp | 2q | +51.1%+$2.3M | |
| PAYONEER GLOBAL INC | PAYO | $6.9M | 967,672 | +0.03pp | 21q | +100.0%+$3.4M | |
| ELUTIA INC | ELUT | $6.2M | 6,369,894 | -0.02pp | 12q | +100.0%+$3.1M | |
| KAILERA THERAPEUTICS INC | KLRA | $6.2M | 280,000 | - | new | NEW | |
| RALLYBIO CORP | RLYB | $6.0M | 376,844 | flat | 2q | +25.3%+$1.2M | |
| ARTIVA BIOTHERAPEUTICS INC | ARTV | $5.8M | 600,000 | - | new | NEW | |
| DESTINATION XL GROUP INC | DXLG | $5.5M | 8,283,480 | +0.01pp | 5q | +100.0%+$2.8M | |
| EDITAS MEDICINE INC | EDIT | $5.5M | 1,705,400 | - | new | NEW | |
| EHEALTH INC | EHTH | $5.2M | 3,522,882 | flat | 14q | +100.0%+$2.6M | |
| JATT II ACQUISITION CORP | $5.1M | 450,000 | - | new | NEW | ||
| ARVINAS INC | ARVN | $5.0M | 600,000 | -0.03pp | 3q | +100.0%+$2.5M | |
| READING INTL INC | RDI | $4.9M | 3,842,176 | flat | 25q | +100.0%+$2.5M | |
| INSPIREMD INC | NSPR | $4.7M | 6,752,968 | -0.12pp | 13q | +100.0%+$2.4M | |
| AYTU BIOPHARMA INC | AYTU | $4.7M | 2,173,624 | -0.03pp | 14q | +100.0%+$2.3M | |
| AKEBIA THREAPEUTICS INC | AKBA | $4.6M | 4,000,000 | -0.03pp | 6q | +100.0%+$2.3M | |
| SCULLY ROYALTY LTD | SRL | $4.5M | 736,364 | -0.03pp | 29q | +100.0%+$2.3M | |
| ENTRADA THERAPEUTICS INC | TRDA | $4.4M | 601,150 | flat | 2q | +277.3%+$3.3M | |
| GAIA INC NEW | GAIA | $3.8M | 1,829,236 | -0.03pp | 14q | +100.0%+$1.9M | |
| AMERICAS CAR-MART INC | CRMT | $3.6M | 1,289,372 | -0.24pp | 15q | +100.0%+$1.8M | |
| ALX ONCOLOGY HLDGS INC | ALXO | $3.1M | 1,500,000 | - | new | NEW | |
| PRECISION OPTICS CORP INC MA | POCI | $2.9M | 560,000 | flat | 2q | +100.0%+$1.4M | |
| BRC INC | BRCC | $2.8M | 2,514,342 | -0.03pp | 4q | -4.4%-$129.0K | |
| VYNE THERAPEUTICS INC | VYNE | $2.6M | 4,000,000 | flat | 3q | +100.0%+$1.3M | |
| ALTISOURCE PORTFOLIO SOLUTIO | ASPSW | $2.0M | 4,954,624 | flat | 5q | +100.0%+$990.9K | |
| ACME UTD CORP | ACU | $1.9M | 40,854 | flat | 6q | +100.0%+$974.8K | |
| PERFECT CORP | PERF | $1.9M | 1,167,850 | flat | 10q | +100.0%+$969.3K | |
| ALTISOURCE PORTFOLIO SOLUTIO | ASPSZ | $1.4M | 4,954,624 | flat | 5q | +100.0%+$693.6K | |
| CELLECTAR BIOSCIENCES INC | CLRB | $1.2M | 439,996 | - | new | NEW | |
| SPAR GROUP INC | SGRP | $1.1M | 1,321,376 | flat | 16q | +100.0%+$545.9K | |
| CURIS INC | CRISXXXX | $1.0M | 1,978,876 | -0.02pp | 2q | -1.1%-$11.0K | |
| SENTI BIOSCIENCES HOLDINGS I | $976.8K | 888,000 | - | new | NEW | ||
| AZITRA INC | AZTR | $742.9K | 4,427,226 | - | new | NEW | |
| BIOMX INC | PHGE | $430.5K | 1,269,990 | -0.01pp | 3q | +1006.3%+$391.6K | |
| APREA THERAPEUTICS INC | APRE | $330.2K | 411,520 | flat | 10q | +100.0%+$165.1K | |
| GUARDFORCE AI CO LTD | GFAIW | $10.8K | 308,410 | flat | 20q | +100.0%+$5.4K |
By sector
Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.
| Sector | Value | Share |
|---|---|---|
| Biotech & Pharma | $2.0B | 34.0% |
| Medical Devices | $623.5M | 10.4% |
| Business Services | $309.8M | 5.1% |
| Industrials | $283.3M | 4.7% |
| Retail & Consumer | $258.3M | 4.3% |
| Wholesale & Distribution | $239.2M | 4.0% |
| Banks & Lending | $231.9M | 3.9% |
| Software & IT Services | $131.9M | 2.2% |
| Telecom & Media | $117.3M | 1.9% |
| Instruments & Controls | $98.0M | 1.6% |
| Other sectors | $192.8M | 3.2% |
| Not classified | $1.5B | 24.7% |
Quarter by quarter
| Quarter | Value | Positions | New | Added | Trimmed | Exited | Top 10 | Days to file |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | $6.0B | 141 | 26 | 103 | 7 | 22 | 45.3% | 45 |
| Q1 2026 | $2.7B | 137 | 17 | 42 | 24 | 22 | 45.6% | 45 |
| Q4 2025 | $3.0B | 142 | 19 | 28 | 30 | 20 | 50.3% | 44 |
| Q3 2025 | $2.9B | 143 | 21 | 23 | 30 | 25 | 47.0% | 45 |
| Q2 2025 | $2.6B | 147 | 25 | 39 | 13 | 11 | 53.5% | 45 |
| Q1 2025 | $2.5B | 133 | 20 | 38 | 38 | 14 | 64.2% | 45 |
| Q4 2024 | $2.3B | 127 | 16 | 41 | 26 | 20 | 58.2% | 45 |
| Q3 2024 | $2.0B | 131 | 18 | 4 | 103 | 8 | 57.5% | 45 |
| Q2 2024 | $3.4B | 121 | 21 | 92 | 4 | 18 | 62.3% | 45 |
| Q1 2024 | $1.8B | 118 | 21 | 3 | 91 | 19 | 57.8% | 45 |
| Q4 2023 | $3.3B | 116 | 18 | 89 | 6 | 22 | 60.2% | 45 |
| Q3 2023 | $1.2B | 120 | 24 | 28 | 33 | 18 | 54.0% | 45 |
| Q2 2023 | $1.0B | 114 | 19 | 19 | 44 | 20 | 54.2% | 45 |
| Q1 2023 | $1.3B | 115 | 19 | 28 | 39 | 14 | 58.5% | 45 |
| Q4 2022 | $1.5B | 110 | 24 | 18 | 39 | 21 | 62.9% | 45 |
| Q3 2022 | $1.5B | 107 | 17 | 16 | 58 | 24 | 57.9% | 41 |
| Q2 2022 | $2.0B | 114 | 14 | 29 | 46 | 15 | 55.7% | 46 |
| Q1 2022 | $2.3B | 115 | 13 | 23 | 65 | 20 | 59.0% | 43 |
| Q4 2021 | $2.8B | 122 | 19 | 30 | 31 | 20 | 52.0% | 45 |
| Q3 2021 | $3.2B | 123 | 24 | 19 | 44 | 17 | 49.1% | 46 |
| Q2 2021 | $3.5B | 116 | 22 | 25 | 35 | 14 | 51.7% | 47 |
| Q1 2021 | $3.4B | 108 | 33 | 19 | 41 | 31 | 57.3% | 44 |
| Q4 2020 | $3.2B | 106 | 23 | 32 | 28 | 23 | 51.8% | 47 |
| Q3 2020 | $3.3B | 106 | 21 | 32 | 22 | 21 | 60.5% | 47 |
| Q2 2020 | $3.3B | 106 | 18 | 20 | 25 | 7 | 57.6% | 45 |
| Q1 2020 | $2.7B | 95 | 23 | 33 | 4 | 8 | 63.8% | 44 |
| Q4 2019 | $3.2B | 80 | 6 | 18 | 15 | 10 | 60.4% | 45 |
| Q3 2019 | $2.7B | 84 | 10 | 19 | 11 | 12 | 52.9% | 45 |
| Q2 2019 | $3.2B | 86 | 10 | 38 | 10 | 7 | 52.1% | 45 |
| Q1 2019 | $3.2B | 83 | 8 | 14 | 30 | 16 | 61.2% | 45 |
| Q4 2018 | $3.3B | 91 | 0 | 0 | 0 | 0 | 58.2% | 45 |
Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.
Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.
Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.